Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Diabetes Obes Metab. 2022 Nov 10;25(2):570–580. doi: 10.1111/dom.14903

Figure 3. The Effect of Treatment on PAI-1 and MCP-1.

Figure 3.

Plots show mean ± SEM for (A) PAI-1 and (B) MCP-1 at 2 and 14 weeks of treatment as change from baseline. Asterisk (*) symbols indicate P<0.05 for estimates of change from baseline, and brackets indicate difference between treatments at 14 weeks. PAI-1 indicates plasminogen activator inhibitor-1; MCP-1, monocyte chemoattractant protein-1.